ARTICLE | Clinical News
KAI-4169: Preliminary Phase I data
July 26, 2010 7:00 AM UTC
Preliminary data from a double-blind, placebo-controlled, Australian Phase I trial in 32 healthy volunteers showed that single-ascending doses of IV KAI-4169 were well tolerated and led to dose-depend...